Jersey tax on cosmetic and large OP (outpatient) surgery ahead:
This article was originally published in Clinica
New Jersey's state legislature has decided to tax certain surgical procedures as one way of bridging the state's budget gap. One bill that recently cleared both legislative chambers assesses a 6% gross receipts tax on cosmetic medical procedures, defined by the state as any procedures that do not meaningfully promote the proper functioning of the body or prevent or treat illness or disease. A second bill slaps a 3.5% gross receipts tax on ambulatory surgical centres, or outpatient (OP) surgery units that have gross receipts higher than $300,000. Although a coalition of medical groups is making a last-ditch effort to overturn the bills they describe as arbitrary and discriminatory, New Jersey Governor James McGreevey is expected to sign the legislation.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.